Using two blood tests to guide antibiotic use for COPD flare-ups
Part of Lungs & breathing clinical trials.
This trial uses two simple blood tests (MxA and CRP) to help doctors decide whether you need antibiotics for a COPD flare-up. It aims to use medicines more wisely and avoid unnecessary side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 40 years old or older.
- You are a current or former smoker with at least 10 pack-years of smoking history (for example, a pack a day for 10 years).
- You have mild-to-severe COPD and are currently having a flare-up that is not severe enough to need emergency hospitalization.
- You have not had a stroke, heart attack, or major surgery in the last 30 days.
- You have not received any vaccines or interferon therapy in the past 30 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a structured care program for COPD can lower how often your symptoms flare up. It may help by improving everyday management and preventing future worsening.
This study tests whether using a blood test called CRP can help doctors decide when antibiotics are needed during a COPD flare-up. It may reduce unnecessary antibiotics while still treating infections when they’re likely.
This trial checks whether using fast test results (PCR from samples, a blood marker called procalcitonin, and sputum appearance) can safely reduce how long you need antibiotics during a severe COPD flare. It may help you receive fewer days of antibiotics while still controlling the infection risk.
This study uses a simple blood test to help doctors decide if people having a COPD flare-up need antibiotics or steroids. It may help you get the right treatment faster and avoid unnecessary medications.
This trial compares customized durations of antibiotics to standard durations for treating acute worsening of COPD. It aims to see if stopping antibiotics early when symptoms improve is as effective as the usual fixed course.
This trial tests whether a simple blood test for a marker called Interleukin-6 (IL-6) can help doctors decide when antibiotics are needed for patients hospitalized with a COPD flare-up (AECOPD). The goal is to reduce unnecessary antibiotics.
Hear when a new Acute Exacerbation Chronic Obstructive Pulmonary Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.